| James Roy Cooper, CRNA | |
|
2001 Errecart Blvd, Northeastern Nevada Regional Hospital, Elko, NV 89801 | |
| (775) 738-5151 | |
| Not Available |
| Full Name | James Roy Cooper |
|---|---|
| Gender | Male |
| Speciality | Certified Registered Nurse Anesthetist (crna) |
| Experience | 24 Years |
| Location | 2001 Errecart Blvd, Elko, Nevada |
| Accepts Medicare Assignments | May be. He may accept the Medicare-approved amount; you may be billed for more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1487605648 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 367500000X | Nurse Anesthetist, Certified Registered | CRNA000182 (Nevada) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Centennial Hills Hospital Medical Center | Las vegas, NV | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Anesthesia Development Partners Llc | 5193180610 | 3 |
| Carson Tahoe Physician Hospital Organization, Llc | 8628465721 | 25 |
| Red Rock Anesthesia Consultants Llc | 4284910290 | 73 |
News Archive
In a world of seemingly endless opportunities for finding a mate, competition for a partner can be fierce. Not all that glitters is gold, as the old adage goes.
An interactive computer software program appears to be effective in helping patients manage their Type 2 diabetes using their mobile phones, according to a new study by University of Maryland School of Medicine researchers.
Biosafe is proud to report that it has just received the official registration of its single use disposable kits with the Chinese FDA. Following earlier approval of the Company's Sepax cell processing machine, Biosafe is now primed to launch sales of its products in the People's Republic of China.
A study published this month by researchers at the University of Toronto and Toronto's Princess Margaret Hospital has shown that cells derived from the umbilical cord, "Human Umbilical Cord PeriVascular Cells" (HUCPVCs), are more effective in restoring heart function after an acute myocardial infarction (in common parlance, a heart attack) in a pre-clinical model than a similar cell population derived from bone marrow.
Lorus Therapeutics Inc. today announced that the Food and Drug Administration completed its review and cleared the company's Investigational New Drug (IND) application of LOR-253 for the treatment of hematologic malignancies including acute myeloid leukemia (AML), high-risk myelodysplastic syndromes (MDS), lymphomas and multiple myeloma.
› Verified 4 days ago
| Entity Name | Red Rock Anesthesia Consultants Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1235660002 PECOS PAC ID: 4284910290 Enrollment ID: O20170405001723 |
News Archive
In a world of seemingly endless opportunities for finding a mate, competition for a partner can be fierce. Not all that glitters is gold, as the old adage goes.
An interactive computer software program appears to be effective in helping patients manage their Type 2 diabetes using their mobile phones, according to a new study by University of Maryland School of Medicine researchers.
Biosafe is proud to report that it has just received the official registration of its single use disposable kits with the Chinese FDA. Following earlier approval of the Company's Sepax cell processing machine, Biosafe is now primed to launch sales of its products in the People's Republic of China.
A study published this month by researchers at the University of Toronto and Toronto's Princess Margaret Hospital has shown that cells derived from the umbilical cord, "Human Umbilical Cord PeriVascular Cells" (HUCPVCs), are more effective in restoring heart function after an acute myocardial infarction (in common parlance, a heart attack) in a pre-clinical model than a similar cell population derived from bone marrow.
Lorus Therapeutics Inc. today announced that the Food and Drug Administration completed its review and cleared the company's Investigational New Drug (IND) application of LOR-253 for the treatment of hematologic malignancies including acute myeloid leukemia (AML), high-risk myelodysplastic syndromes (MDS), lymphomas and multiple myeloma.
› Verified 4 days ago
| Entity Name | Western Anesthesia Provider Group-scherr, P.c. |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1801450572 PECOS PAC ID: 6204160385 Enrollment ID: O20190624001551 |
News Archive
In a world of seemingly endless opportunities for finding a mate, competition for a partner can be fierce. Not all that glitters is gold, as the old adage goes.
An interactive computer software program appears to be effective in helping patients manage their Type 2 diabetes using their mobile phones, according to a new study by University of Maryland School of Medicine researchers.
Biosafe is proud to report that it has just received the official registration of its single use disposable kits with the Chinese FDA. Following earlier approval of the Company's Sepax cell processing machine, Biosafe is now primed to launch sales of its products in the People's Republic of China.
A study published this month by researchers at the University of Toronto and Toronto's Princess Margaret Hospital has shown that cells derived from the umbilical cord, "Human Umbilical Cord PeriVascular Cells" (HUCPVCs), are more effective in restoring heart function after an acute myocardial infarction (in common parlance, a heart attack) in a pre-clinical model than a similar cell population derived from bone marrow.
Lorus Therapeutics Inc. today announced that the Food and Drug Administration completed its review and cleared the company's Investigational New Drug (IND) application of LOR-253 for the treatment of hematologic malignancies including acute myeloid leukemia (AML), high-risk myelodysplastic syndromes (MDS), lymphomas and multiple myeloma.
› Verified 4 days ago
| Entity Name | Carson Tahoe Physician Hospital Organization, Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1063169829 PECOS PAC ID: 8628465721 Enrollment ID: O20220419002777 |
News Archive
In a world of seemingly endless opportunities for finding a mate, competition for a partner can be fierce. Not all that glitters is gold, as the old adage goes.
An interactive computer software program appears to be effective in helping patients manage their Type 2 diabetes using their mobile phones, according to a new study by University of Maryland School of Medicine researchers.
Biosafe is proud to report that it has just received the official registration of its single use disposable kits with the Chinese FDA. Following earlier approval of the Company's Sepax cell processing machine, Biosafe is now primed to launch sales of its products in the People's Republic of China.
A study published this month by researchers at the University of Toronto and Toronto's Princess Margaret Hospital has shown that cells derived from the umbilical cord, "Human Umbilical Cord PeriVascular Cells" (HUCPVCs), are more effective in restoring heart function after an acute myocardial infarction (in common parlance, a heart attack) in a pre-clinical model than a similar cell population derived from bone marrow.
Lorus Therapeutics Inc. today announced that the Food and Drug Administration completed its review and cleared the company's Investigational New Drug (IND) application of LOR-253 for the treatment of hematologic malignancies including acute myeloid leukemia (AML), high-risk myelodysplastic syndromes (MDS), lymphomas and multiple myeloma.
› Verified 4 days ago
| Entity Name | Anesthesia Development Partners Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1073227815 PECOS PAC ID: 5193180610 Enrollment ID: O20230504002699 |
News Archive
In a world of seemingly endless opportunities for finding a mate, competition for a partner can be fierce. Not all that glitters is gold, as the old adage goes.
An interactive computer software program appears to be effective in helping patients manage their Type 2 diabetes using their mobile phones, according to a new study by University of Maryland School of Medicine researchers.
Biosafe is proud to report that it has just received the official registration of its single use disposable kits with the Chinese FDA. Following earlier approval of the Company's Sepax cell processing machine, Biosafe is now primed to launch sales of its products in the People's Republic of China.
A study published this month by researchers at the University of Toronto and Toronto's Princess Margaret Hospital has shown that cells derived from the umbilical cord, "Human Umbilical Cord PeriVascular Cells" (HUCPVCs), are more effective in restoring heart function after an acute myocardial infarction (in common parlance, a heart attack) in a pre-clinical model than a similar cell population derived from bone marrow.
Lorus Therapeutics Inc. today announced that the Food and Drug Administration completed its review and cleared the company's Investigational New Drug (IND) application of LOR-253 for the treatment of hematologic malignancies including acute myeloid leukemia (AML), high-risk myelodysplastic syndromes (MDS), lymphomas and multiple myeloma.
› Verified 4 days ago
| Entity Name | Amin Dunckelmeyer And Luu Pllc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1093410045 PECOS PAC ID: 4385002682 Enrollment ID: O20230619001249 |
News Archive
In a world of seemingly endless opportunities for finding a mate, competition for a partner can be fierce. Not all that glitters is gold, as the old adage goes.
An interactive computer software program appears to be effective in helping patients manage their Type 2 diabetes using their mobile phones, according to a new study by University of Maryland School of Medicine researchers.
Biosafe is proud to report that it has just received the official registration of its single use disposable kits with the Chinese FDA. Following earlier approval of the Company's Sepax cell processing machine, Biosafe is now primed to launch sales of its products in the People's Republic of China.
A study published this month by researchers at the University of Toronto and Toronto's Princess Margaret Hospital has shown that cells derived from the umbilical cord, "Human Umbilical Cord PeriVascular Cells" (HUCPVCs), are more effective in restoring heart function after an acute myocardial infarction (in common parlance, a heart attack) in a pre-clinical model than a similar cell population derived from bone marrow.
Lorus Therapeutics Inc. today announced that the Food and Drug Administration completed its review and cleared the company's Investigational New Drug (IND) application of LOR-253 for the treatment of hematologic malignancies including acute myeloid leukemia (AML), high-risk myelodysplastic syndromes (MDS), lymphomas and multiple myeloma.
› Verified 4 days ago
| Mailing Address | Practice Location Address |
|---|---|
| James Roy Cooper, CRNA Po Box 2723, Elko, NV 89803 Ph: (775) 778-6634 | James Roy Cooper, CRNA 2001 Errecart Blvd, Northeastern Nevada Regional Hospital, Elko, NV 89801 Ph: (775) 738-5151 |
News Archive
In a world of seemingly endless opportunities for finding a mate, competition for a partner can be fierce. Not all that glitters is gold, as the old adage goes.
An interactive computer software program appears to be effective in helping patients manage their Type 2 diabetes using their mobile phones, according to a new study by University of Maryland School of Medicine researchers.
Biosafe is proud to report that it has just received the official registration of its single use disposable kits with the Chinese FDA. Following earlier approval of the Company's Sepax cell processing machine, Biosafe is now primed to launch sales of its products in the People's Republic of China.
A study published this month by researchers at the University of Toronto and Toronto's Princess Margaret Hospital has shown that cells derived from the umbilical cord, "Human Umbilical Cord PeriVascular Cells" (HUCPVCs), are more effective in restoring heart function after an acute myocardial infarction (in common parlance, a heart attack) in a pre-clinical model than a similar cell population derived from bone marrow.
Lorus Therapeutics Inc. today announced that the Food and Drug Administration completed its review and cleared the company's Investigational New Drug (IND) application of LOR-253 for the treatment of hematologic malignancies including acute myeloid leukemia (AML), high-risk myelodysplastic syndromes (MDS), lymphomas and multiple myeloma.
› Verified 4 days ago
Ronnie Jay Wing, CRNA Nurse Anesthetist - CR Medicare: May Accept Medicare Assignments Practice Location: 1775 Browning Way Ste 102, Elko, NV 89801 Phone: 775-299-4555 Fax: 775-525-5257 | |
Jim Thach Nguyen, CRNA Nurse Anesthetist - CR Medicare: Accepting Medicare Assignments Practice Location: 2001 Errecart Blvd, Elko, NV 89801 Phone: 775-738-5151 | |
Mr. Richard Charles Kidwell, CRNA Nurse Anesthetist - CR Medicare: Not Enrolled in Medicare Practice Location: 855 Golf Course Rd, Elko, NV 89801 Phone: 775-753-4700 Fax: 775-753-4703 | |
Christopher Jerome Weisenfels, CRNA Nurse Anesthetist - CR Medicare: Accepting Medicare Assignments Practice Location: 2001 Errecart Blvd, Northeastern Nevada Regional Hospital, Elko, NV 89801 Phone: 775-738-5151 | |
Arthur Savignac, CRNA Nurse Anesthetist - CR Medicare: Accepting Medicare Assignments Practice Location: 2001 Errecart Blvd, Northeastern Nevada Regional Hospital, Elko, NV 89801 Phone: 775-738-5151 |